By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Barr Laboratories 

2 Quaker Road

Pomona  New York  10970-2930  U.S.A.
Phone: 914-348-8050 Fax:



Company News
Unity Management Group Receives Large Purchase Order for their AIM Instrumentation Package From Barr Laboratories (BRL), Subdivision of Teva Pharmaceutical Industries Limited (TEVA) (NASDAQ: TEVA) 10/12/2011 11:39:38 AM
Kentucky Reaches $10M Settlement With TEVA Pharmaceuticals USA (TEVA), IVAX Pharmaceuticals, Inc. (IVX), Barr Laboratories (BRL), Sicor Inc. (SCRI), IVAX Corporation (IVX) and Teva Women's Health, Inc. (Formerly Known as Duramed Pharmaceuticals, Inc.) (TEVA) 8/16/2010 7:25:17 AM
Celgene (CELG) Says Barr Laboratories (BRL) Withdrew Generic Thalomid Filing; Dismisses Suit Against Barr 5/27/2010 8:13:05 AM
Barr Laboratories (BRL) Issues a Voluntary Nationwide Recall of Dextroamphetamine/Amphetamine 20mg Tablets 8/14/2009 8:13:07 AM
Shire plc Files Lawsuit Against Barr Laboratories (BRL) for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patents 3/16/2009 11:21:47 AM
Barr Laboratories (BRL), Mylan Inc. (MYL) Plan Generics of Shire plc's Fosrenol Drug 2/9/2009 6:29:52 AM
Teva Pharmaceutical Industries Limited (TEVA) Completes Acquisition of Barr Laboratories (BRL) 12/23/2008 8:58:08 AM
Teva Pharmaceutical Industries Limited (TEVA), Barr Laboratories (BRL) Say FTC Seeks More Merger Information 9/4/2008 6:58:42 AM
Barr Laboratories (BRL) Announces Favorable Ruling in Razadyne(R) Patent Challenge 8/28/2008 8:01:46 AM
Christine Mundkur Named CEO of Barr Laboratories (BRL); Fred Wilkinson Named CEO of Duramed Pharmaceuticals, Inc. (BRL) 3/28/2008 7:03:49 AM